Abram Scientific
Abram Scientific is focused on advancing coagulation diagnostics with its patented CoagCare platform, offering fast, accurate, and actionable hemostasis information for point-of-care use.
Based in the San Francisco Bay Area, Abram Scientific was founded by Dr. Abhishek Ramkumar, CEO, and inventor of the CoagCare platform technology. The company’s proprietary technology is protected by 17 U.S. and internationally granted patents, with additional patent applications currently under prosecution.
Abram’s CoagCare System is a novel diagnostic platform designed for the diagnosis and characterization of coagulation-related disorders. The system delivers rapid, accurate hemostasis information to improve clinical outcomes, particularly in managing blood clotting or bleeding disorders. The CoagCare system is a point-of-care (POC) device that employs a single-use diagnostic test card, providing clinicians with quick results in under 10 minutes.
The platform utilizes proprietary technology to measure blood viscoelasticity and density, enabling a comprehensive assessment of the entire blood coagulation cascade—from clot formation to fibrinolysis. This rapid analysis supports the detection of coagulation abnormalities and guides therapy for optimal coagulation management, offering a crucial tool for better patient outcomes in diverse clinical settings.
